I Peace

I Peace operates as a specialized CDMO in the iPSC space, leveraging a proprietary automated manufacturing platform to produce clinical and research-grade iPSCs at scale. The company's business model is dual-faceted, serving both institutional clients (biotech/pharma) with GMP manufacturing and drug discovery services, and individuals with personal cell banking. Through strategic partnerships and a platform aimed at connecting patient donors with researchers, I Peace seeks to overcome the chronic shortage of renewable, patient-specific cell samples that slow R&D in cell therapy.

Proprietary automated manufacturing platform using robotics and fluidics for scalable, cost-effective production of clinical and research-grade induced pluripotent stem cells (iPSCs).

I Peace competes with other stem cell-focused CDMOs (e.g., Fujifilm Cellular Dynamics, Lonza, Takara Bio) and life science tools companies offering iPSC lines and services. Its key differentiator is its emphasis on full automation for mass production of personalized lines, aiming for lower cost and higher throughput than conventional manual methods.